http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
A Collaborative decision making for distributed detection system
Ashfaq Hussain Farooqi(아쉬팍 후세인 파루키),Wang Jin(왕진),Farrukh Aslam Khan(파루크 아슬람 칸),Sungyoung Lee(이승룡) 한국정보과학회 2011 한국정보과학회 학술발표논문집 Vol.38 No.1D
Intrusion detection systems (IDS) are supposed to be an efficient safety measure against inside attacks. In purely distributed IDS approach, IDS agent is installed in every node. It checks abnormal behavior of neighboring nodes locally. It collects the data that it receives from nodes in its radio range. Sensor nodes audit that data and generate alerts for abnormal activity. Here, there are two ways of taking decision. First, it can take decision individually and second, it can communicate with its neighbor to find the status of the claimed compromised nodes. In this paper, we propose a collaborative decision making scheme for purely distributed detection system. The proposed scheme is light weight compared to consensus based validation methodology. It provides a better scheme to find intrusions by interacting with other nodes.
Zahoor Hussain Farooqi,Shanza Rauf Khan,Tajamal Hussain,Robina Begum,Kiran Ejaz,Shumaila Majeed,Muhammad Ajmal,Farah Kanwal,Mohammad Siddiq 한국화학공학회 2014 Korean Journal of Chemical Engineering Vol.31 No.9
We investigated the effect of crosslinking density of poly(N-isopropyl acrylamide-co-acrylic acid) micro-gels on catalytic activity of silver nanoparticles fabricated hybrid microgels. Multiresponsive poly(N-isopropyl acryla-mide-co-acrylic acid) microgels with 2, 4, 6 and 8 mole percentage of N,N-methylene-bis-acrylamide were synthesizedby emulsion polymerization. These microgels were characterized by dynamic light scattering and were used as mi-croreactors to synthesize silver nanoparticles. Hybrid system was characterized by ultraviolet-visible spectroscopy. Thecatalytic activity of hybrid microgels with different crosslinker content was compared by studying the reduction of p-nitrophenol as a model reaction. Kinetics of reaction was monitored by spectrophotometry. The value of the apparentrate constant decreases from 0.568 to 0.313 min−1, when content of crosslinker are increased from 2 to 8 mole percent-age respectively. This decreases in value of apparent rate constant is due to increase in diffusional barrier offered byhigh crosslinking of polymer network at high mole percentages of N,N-methylene-bis-acrylamide.
Arsenic(V) biosorption by charred orange peel in aqueous environments
Abid, Muhammad,Niazi, Nabeel Khan,Bibi, Irshad,Farooqi, Abida,Ok, Yong Sik,Kunhikrishnan, Anitha,Ali, Fawad,Ali, Shafaqat,Igalavithana, Avanthi Deshani,Arshad, Muhammad Taylor Francis 2016 International journal of phytoremediation Vol.18 No.5
Current Status of Immunotherapeutic Strategies for Central Nervous System Tumors
Yang, Meng-Yin,Khan-Farooqi, Haumith,Prins, Robert M.,Liau, Linda M. The Korean Neurosurgical Society 2006 Journal of Korean neurosurgical society Vol.40 No.4
Malignant gliomas are the most common type of primary brain tumor and are in great need of novel therapeutic approaches. Advances in treatment have been very modest, significant improvement in survival has been lacking for many decades, and prognosis remains dismal. Despite "gross total" surgical resections and currently available radio-chemotherapy, malignant gliomas inevitably recur due to reservoirs of notoriously invasive tumor cells that infiltrate adjacent and non-adjacent areas of normal brain parenchyma. In principle, the immune system is uniquely qualified to recognize and target these infiltrative pockets of tumors cells, which have generally eluded conventional treatment approaches, In the span of the last 10 years, our understanding of the cancer-immune system relationship has increased exponentially; and yet we are only beginning to tease apart the intricacies of the central nervous system and immune cell interactions. This article reviews the complex associations of the immune system with brain tumors. We provide an overview of currently available treatment options for malignant gliomas, existing gaps in our knowledge of brain tumor immunology, and strategies that might be exploited for improved design of "custom immunotherapeutics." We will also examine major new immunotherapy approaches that are being actively investigated to treat patients with malignant glioma, and identify some current and future research priorities in this area.